The abstract is read at the publisher; the summary is JClub's.
In women with early- and late-stage autosomal dominant polycystic kidney disease in the HALT-PKD trial, pregnancy was not associated with later accelerated eGFR decline.
- Why it matters: Evidence is conflicting on whether pregnancy worsens ADPKD progression, despite prior reports linking adverse pregnancy outcomes to kidney decline. Clarifying this risk informs how closely pregnant patients should be monitored.
- What they did: The study analyzed HALT-PKD participants using multivariable linear regression for eGFR slope and %ΔTKV, and Cox models for a composite outcome (kidney failure, 50% eGFR decline, or death). It compared no pregnancy versus 1–2 pregnancies versus ≥3 pregnancies, and also used propensity matching (1:4) for women with pregnancy during participation (n=13).
- The result: Across adjusted models, 1–2 and ≥3 pregnancies showed no association with eGFR slope, %ΔTKV, or time to the composite outcome (eGFR slope β 0.22 and -0.46; hazard ratios 1.04 and 1.48). In matched analyses, annual eGFR slope and %ΔTKV also did not differ between women who became pregnant and those who did not.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.